Table 1 –

Baseline Patient Characteristics by Cohort

Variable	Pre-Exposure(n = 183)	Post-Exposure(n = 179)	p-value
Age at Transplant (years), median (IQR)	58 (52, 64)	58.0 (50, 63)	0.32
Male Sex	124 (67.8%)	130 (72.6%)	0.31
Race			0.70
White	131 (71.6%)	136 (76.0%)
Black	33 (18.0%)	27 (15.1%)
Asian	5 (2.7%)	6 (3.4%)
Other/unknown	14 (7.7%)	10 (5.6%)
Body Mass Index, median (IQR)	27.5 (23.6, 32.6)	26.6 (24.3, 30.7)	0.48
Etiology of Liver Disease			0.07
Hepatitis C	75 (41.4%)	63 (35.2%)
Hepatitis B	1 (0.6%)	8 (4.5%)
Alcoholic Liver Disease	30 (16.6%)	42 (23.5%)
NAFLD	24 (13.3%)	16 (8.9%)
Autoimmune	32 (17.7%)	32 (17.9%)
Other	19 (10.5%)	18 (10.1%)
MELD-Na, median (IQR)	20 (15, 25)	18 (12, 28)	0.20
MELD Exceptions Granted	18 (9.8%)	41 (22.9%)	<0.001*
Exception for Hepatocellular Carcinoma	17 (9.3%)	38 (21.2%)	0.002*
MELD-Na with Exceptions, median (IQR)	22 (16, 27)	23 (15, 30)	0.22
Dialysis Status			0.39
No HD	149 (81.9%)	153 (85.5%)
Peri-transplant HD	33 (18.1%)	26 (14.5%)
Transplant type			0.08
Inpatient	51 (27.9%)	36 (20.1%)
Elective	132 (72.1%)	143 (79.9%)
Retransplant on Index Admission	4 (2.2%)	5 (2.8%)	0.75
Total Length of Stay (days), median (IQR)	11 (8, 19)	9.0 (7, 17)	0.13
Post-op Length of Stay (days), median (IQR)	9 (7, 13)	9.0 (7, 13)	0.41
Weekend Discharge	22 (12%)	26 (14%)	0.48
Index Hospitalization Disposition			0.13
Home	129 (70.9%)	137 (76.5%)
Rehab	48 (26.4%)	33 (18.4%)
Skilled Nursing Facility/Long-term Care	5 (2.7%)	9 (5.0%)
Distance to Transplant Center (miles), median (IQR)	30.1 (13.5, 82.4)	33.6 (15.0, 66.3)	0.75

^*Statistically significant at the alpha = 0.05 level

IQR = interquartile range; NAFLD = non-alcoholic fatty liver disease; MELD = model for end-stage liver disease; HD = hemodialysis